NO984160L - FremgangsmÕte for behandling eller forebyggelse av interstitiell cystitt - Google Patents

FremgangsmÕte for behandling eller forebyggelse av interstitiell cystitt

Info

Publication number
NO984160L
NO984160L NO984160A NO984160A NO984160L NO 984160 L NO984160 L NO 984160L NO 984160 A NO984160 A NO 984160A NO 984160 A NO984160 A NO 984160A NO 984160 L NO984160 L NO 984160L
Authority
NO
Norway
Prior art keywords
prevention
treatment
interstitial cystitis
procedure
mammal
Prior art date
Application number
NO984160A
Other languages
English (en)
Other versions
NO984160D0 (no
Inventor
Smriti Iyengar
Mark A Muhlhauser
Karl B Thor
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984160D0 publication Critical patent/NO984160D0/no
Publication of NO984160L publication Critical patent/NO984160L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Threshing Machine Elements (AREA)
  • Processing Of Meat And Fish (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nozzles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transplanting Machines (AREA)
  • Pistons, Piston Rings, And Cylinders (AREA)
  • Heat Treatment Of Articles (AREA)
  • Steroid Compounds (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO984160A 1996-03-11 1998-09-10 FremgangsmÕte for behandling eller forebyggelse av interstitiell cystitt NO984160L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1315796P 1996-03-11 1996-03-11
PCT/US1997/003410 WO1997033880A1 (en) 1996-03-11 1997-03-07 Methods of treating or preventing interstitial cystitis

Publications (2)

Publication Number Publication Date
NO984160D0 NO984160D0 (no) 1998-09-10
NO984160L true NO984160L (no) 1998-09-10

Family

ID=21758595

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984160A NO984160L (no) 1996-03-11 1998-09-10 FremgangsmÕte for behandling eller forebyggelse av interstitiell cystitt

Country Status (23)

Country Link
EP (1) EP0888330B1 (no)
JP (1) JP2000506863A (no)
KR (1) KR19990087671A (no)
CN (1) CN1217721A (no)
AT (1) ATE239467T1 (no)
AU (1) AU730448B2 (no)
BR (1) BR9708027A (no)
CA (1) CA2250288A1 (no)
CZ (1) CZ287798A3 (no)
DE (1) DE69721747T2 (no)
DK (1) DK0888330T3 (no)
EA (1) EA001325B1 (no)
ES (1) ES2197993T3 (no)
HU (1) HUP9902884A3 (no)
IL (1) IL126159A (no)
NO (1) NO984160L (no)
NZ (1) NZ331811A (no)
PL (1) PL328959A1 (no)
PT (1) PT888330E (no)
RO (1) RO117296B1 (no)
UA (1) UA62926C2 (no)
WO (1) WO1997033880A1 (no)
YU (1) YU39598A (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9913671A (pt) 1998-09-15 2001-06-05 Lilly Co Eli Tratamento da dor persistente
WO2002078691A1 (en) * 2001-03-29 2002-10-10 Eli Lilly And Company Duloxetine for treatment of hot flashes
JP2005526079A (ja) * 2002-03-15 2005-09-02 サイプレス バイオサイエンス， インコーポレイテッド 内蔵痛症候群を処置するためのｎｅおよび５−ｈｔ再取り込み阻害剤
DE10247689A1 (de) * 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
WO2007034503A2 (en) * 2005-06-20 2007-03-29 Cadila Healthcare Limited Controlled release dosage formulation of duloxetine
EP2018860A1 (en) * 2007-07-16 2009-01-28 LEK Pharmaceuticals D.D. Duloxetine composition
EP1938840A1 (en) * 2006-12-27 2008-07-02 LEK Pharmaceuticals D.D. Duloxetine composition
US20110008439A1 (en) * 2006-12-27 2011-01-13 Lek Pharmaceuticals D.D. Duloxetin composition
WO2009066181A2 (en) * 2007-07-09 2009-05-28 Combino Pharm, S.L. Oral delayed-release duloxentine hydrochloride pellets
RU2719929C1 (ru) * 2018-12-17 2020-04-23 Юрий Анатольевич Игнашов Способ выбора лечения женщин с синдромом болезненного мочевого пузыря

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US574474A (en) * 1897-01-05 Course-indicating apparatus
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence

Also Published As

Publication number Publication date
DE69721747T2 (de) 2004-04-01
EP0888330B1 (en) 2003-05-07
DE69721747D1 (de) 2003-06-12
IL126159A (en) 2003-01-12
CN1217721A (zh) 1999-05-26
HUP9902884A2 (en) 2000-07-28
WO1997033880A1 (en) 1997-09-18
ATE239467T1 (de) 2003-05-15
AU730448B2 (en) 2001-03-08
JP2000506863A (ja) 2000-06-06
NZ331811A (en) 2001-04-27
YU39598A (sh) 1999-09-27
ES2197993T3 (es) 2004-01-16
HUP9902884A3 (en) 2000-12-28
RO117296B1 (ro) 2002-01-30
IL126159A0 (en) 1999-05-09
CZ287798A3 (cs) 1999-05-12
PT888330E (pt) 2003-09-30
PL328959A1 (en) 1999-03-01
EP0888330A4 (en) 1999-04-07
EP0888330A1 (en) 1999-01-07
UA62926C2 (en) 2004-01-15
AU2196297A (en) 1997-10-01
DK0888330T3 (da) 2003-09-01
NO984160D0 (no) 1998-09-10
BR9708027A (pt) 1999-08-03
CA2250288A1 (en) 1997-09-18
KR19990087671A (ko) 1999-12-27
EA199800816A1 (ru) 1999-02-25
EA001325B1 (ru) 2001-02-26

Similar Documents

Publication Publication Date Title
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
ATE413386T1 (de) Ppar-gamma modulatoren
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
NO20000786L (no) GABA analoger for forebyggelse og behandling av gastrointestinal skade
NO20056021L (no) Anvendelse av CS-866 til fremstilling av et medikament
ATE232396T1 (de) Oxydiertes thymosin beta 4
TR200000756T2 (tr) Davranış bozukluğu tedavisi.
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
NO984160L (no) FremgangsmÕte for behandling eller forebyggelse av interstitiell cystitt
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
DK1291018T3 (da) Phosphonatananaloger til mannose-6phosphat og deres anvendelse i behandlingen af sår og fibrotiske lidelser
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
NO990450L (no) Behandling av sinnslidelser
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
WO1999031136A3 (en) Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
IL143279A0 (en) Novel therapeutic application of low molecular weight heparin
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
NO984198D0 (no) Fremgangsmåte for behandling av aggresjon
NO984196L (no) FremgangsmÕte for behandling av stoffmisbruk
EA199800818A1 (ru) Способ лечения бессонницы

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application